Colony-stimulating factor use in the context of refined risk and benefit assessments.
Publication
, Journal Article
Crawford, J
Published in: Oncology (Williston Park)
April 2006
Duke Scholars
Published In
Oncology (Williston Park)
ISSN
0890-9091
Publication Date
April 2006
Volume
20
Issue
5 Suppl 4
Start / End Page
9 / 10
Location
United States
Related Subject Headings
- Risk Assessment
- Recombinant Proteins
- Neutropenia
- Neoplasms
- Humans
- Granulocyte-Macrophage Colony-Stimulating Factor
- Granulocyte Colony-Stimulating Factor
- Filgrastim
Citation
APA
Chicago
ICMJE
MLA
NLM
Crawford, J. (2006). Colony-stimulating factor use in the context of refined risk and benefit assessments. Oncology (Williston Park), 20(5 Suppl 4), 9–10.
Crawford, Jeffrey. “Colony-stimulating factor use in the context of refined risk and benefit assessments.” Oncology (Williston Park) 20, no. 5 Suppl 4 (April 2006): 9–10.
Crawford J. Colony-stimulating factor use in the context of refined risk and benefit assessments. Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9–10.
Crawford, Jeffrey. “Colony-stimulating factor use in the context of refined risk and benefit assessments.” Oncology (Williston Park), vol. 20, no. 5 Suppl 4, Apr. 2006, pp. 9–10.
Crawford J. Colony-stimulating factor use in the context of refined risk and benefit assessments. Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9–10.
Published In
Oncology (Williston Park)
ISSN
0890-9091
Publication Date
April 2006
Volume
20
Issue
5 Suppl 4
Start / End Page
9 / 10
Location
United States
Related Subject Headings
- Risk Assessment
- Recombinant Proteins
- Neutropenia
- Neoplasms
- Humans
- Granulocyte-Macrophage Colony-Stimulating Factor
- Granulocyte Colony-Stimulating Factor
- Filgrastim